The Discounted Cash Flow (DCF) valuation of Intra-Cellular Therapies Inc (ITCI) is (4,932.13) USD. With the latest stock price at 126.26 USD, the upside of Intra-Cellular Therapies Inc based on DCF is -4006.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (38,830.41) - (2,669.50) | (4,932.13) |
| Upside | -30854.3% - -2214.3% | -4006.3% |